(Q35480518)

8 August 2017

0 references

1 reference

title

Sex-specific differences in diabetes prevention: a systematic review and meta-analysis (English)

1 reference

8 August 2017

1 reference

1 reference

3

1 reference

8 August 2017

6

Jaakko Tuomilehto

0 references

Megan Van Noord

object named as

Megan Van Noord

7

0 references

Alexandra Kautzky-Willer

object named as

Alexandra Kautzky-Willer

9

0 references

Jürgen Harreiter

object named as

Jürgen Harreiter

2

0 references

author name string

Anna Glechner

1

1 reference

8 August 2017

Sonja Rohleder

4

1 reference

8 August 2017

Alexander Kautzky

5

1 reference

8 August 2017

Angela Kaminski-Hartenthaler

8

1 reference

8 August 2017

3 December 2014

1 reference

8 August 2017

1 reference

8 August 2017

58

1 reference

8 August 2017

2

1 reference

8 August 2017

242-254

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-014-3439-x

8 August 2017

0 references

cites work

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Semi-automating the manual literature search for systematic reviews increases efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

21 January 2018

12 December 2020

GRADE guidelines: 3. Rating the quality of evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Pioglitazone for diabetes prevention in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Predictors of lifestyle intervention outcome and dropout: the SLIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The diabetes prevention program and its global implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Effect of metformin on patients with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

The DREAM trial – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3439-X

Diabetes mellitus. Report of a WHO Study Group

21 January 2018

1 reference

12 December 2020

Effectiveness and cost-effectiveness of diabetes prevention among adherent participants

1 reference

12 December 2020

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

1 reference

12 December 2020

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

12 December 2020

Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study

1 reference

12 December 2020

Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts

1 reference

12 December 2020

10.1007/S00125-014-3439-X

Identifiers

DOI

1 reference

8 August 2017

1 reference